Adjuvanted RSVPreF3 vaccine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01-12 in 4mo
ESTIMATED |
READOUT
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respirat
Phase 2 · Respiratory Syncytial Virus Infections |
GlaxoSmithKline | Adjuvanted RSVPreF3 vaccine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-29
Sponsor-projected date — can change
|